JBF Capital »

Regeneron Pharmaceuticals shares owned by JBF Capital

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by JBF Capital from 13F filings

Historical chart of JBF Capital investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by JBF Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by JBF Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.9M 5.0k 771.87

More positions owned by JBF Capital

Vanguard S&p 500 Etf Etf (VOO)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Green Brick Partners (GRBK)
Invesco Qqq Trust Etf, Series 1 Etf Etf (QQQ)
Facebook Inc cl a (META)
State Street Spdr S&p Biotech Etf Etf Etf (XBI)
Invesco S&p 500 Equal Weight Etf Etf (RSP)
Lowe's Companies (LOW)
NVIDIA Corporation (NVDA)
Netflix (NFLX)
Broadcom (AVGO)
Commercial Bancgroup (CBK)
United Rentals (URI)

View all positions for JBF Capital

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
State Street Corporation
Dodge & Cox
Jpmorgan Chase & Co
Franklin Resources
Geode Capital Management
Nuveen
FMR
Loomis, Sayles and
Invesco
Capital World Investors
Susquehanna International
Goldman Sachs Group
Norges Bank Investment Management

View all funds holding Regeneron Pharmaceuticals